Pamela Vig
Hoofd Techniek/Wetenschap/O&O bij MIRUM PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Pamela Vig
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
| Subsidiary | Pharmaceuticals: Major | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Pamela Vig via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| REPROS THERAPEUTICS INC | Pharmaceuticals: Major | President Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| ZELTIQ AESTHETICS INC | Medical Specialties | Director/Board Member Chief Executive Officer | |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Director/Board Member President | |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Irvine | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | President Treasurer Corporate Secretary | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member President Treasurer Corporate Secretary | |
RightCare Solutions, Inc.
 RightCare Solutions, Inc. Packaged SoftwareTechnology Services Right Care Solutions, Inc. develops a discharge decision support platform. It offers risk assessment by flagging patients at risk for readmissions when admitted to the hospital. The solution also provides recommendations regarding post-acute care and community-based services for patients. The company was founded by Eric M. Heil and Kathyrn H. Bowles in 2011 and is headquartered in Horsham, PA. | Packaged Software | Director/Board Member Director/Board Member | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chairman Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| AKOUOS | Biotechnology | Director/Board Member Director/Board Member | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| ASSERTIO HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Sorriso Pharmaceuticals, Inc.
 Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Chairman Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Ierland | 3 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 38 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 353 |
| Independent Dir/Board Member | 123 |
| Corporate Officer/Principal | 90 |
| Chief Executive Officer | 55 |
| President | 53 |
Sterkste connecties
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Eckard Weber | 46 |
| Jonathan Leff | 45 |
| Patrick Heron | 42 |
| Timothy Walbert | 40 |
| Ambrose Bailey | 32 |
| Michael Grey | 32 |
| Laura Brege | 27 |
| Dennis Podlesak | 27 |
| Carol Brosgart | 25 |
| Tiba Aynechi | 24 |
| Laurent Fischer | 23 |
| Eric Bjerkholt | 21 |
| Gwen Melincoff | 20 |
| Sona Saira Ramasastry | 19 |
- Beurs
- Insiders
- Pamela Vig
- Bedrijfsconnecties
